Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$66.81 - $80.83 $15,232 - $18,429
228 Added 1.73%
13,444 $1.05 Million
Q1 2024

May 15, 2024

SELL
$61.03 - $69.57 $476,095 - $542,715
-7,801 Reduced 37.12%
13,216 $895,000
Q4 2023

Jan 30, 2024

BUY
$61.89 - $69.28 $53,720 - $60,135
868 Added 4.31%
21,017 $1.42 Million
Q3 2023

Oct 23, 2023

SELL
$64.85 - $71.7 $86,380 - $95,504
-1,332 Reduced 6.2%
20,149 $1.36 Million
Q2 2023

Jul 24, 2023

SELL
$69.91 - $75.81 $171,559 - $186,037
-2,454 Reduced 10.25%
21,481 $1.54 Million
Q1 2023

May 12, 2023

SELL
$63.15 - $71.6 $63,844 - $72,387
-1,011 Reduced 4.05%
23,935 $1.66 Million
Q4 2022

Feb 10, 2023

BUY
$54.21 - $70.44 $33,339 - $43,320
615 Added 2.53%
24,946 $1.69 Million
Q3 2022

Nov 09, 2022

BUY
$53.02 - $135.75 $226,978 - $581,145
4,281 Added 21.35%
24,331 $1.33 Million
Q2 2022

Aug 16, 2022

BUY
$59.26 - $71.14 $125,394 - $150,532
2,116 Added 11.8%
20,050 $1.33 Million
Q1 2022

May 13, 2022

SELL
$55.72 - $67.12 $792,839 - $955,050
-14,229 Reduced 44.24%
17,934 $1.19 Million
Q4 2021

Feb 15, 2022

BUY
$54.02 - $63.83 $1.4 Million - $1.65 Million
25,873 Added 411.34%
32,163 $1.87 Million
Q3 2021

Nov 09, 2021

BUY
$55.56 - $60.79 $5,722 - $6,261
103 Added 1.66%
6,290 $378,000
Q2 2021

Aug 13, 2021

SELL
$48.42 - $60.18 $433,020 - $538,189
-8,943 Reduced 59.11%
6,187 $370,000
Q1 2021

May 11, 2021

BUY
$47.16 - $54.44 $260,511 - $300,726
5,524 Added 57.51%
15,130 $752,000
Q4 2020

Feb 10, 2021

BUY
$48.52 - $58.02 $24,793 - $29,648
511 Added 5.62%
9,606 $480,000
Q3 2020

Nov 10, 2020

BUY
$53.07 - $61.1 $67,292 - $77,474
1,268 Added 16.2%
9,095 $498,000
Q2 2020

Aug 05, 2020

BUY
$43.1 - $55.31 $97,147 - $124,668
2,254 Added 40.45%
7,827 $414,000
Q1 2020

May 11, 2020

BUY
$37.79 - $51.33 $35,824 - $48,660
948 Added 20.5%
5,573 $249,000
Q4 2019

Feb 13, 2020

BUY
$42.46 - $50.46 $196,377 - $233,377
4,625 New
4,625 $231,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Svb Wealth LLC Portfolio

Follow Svb Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.